Frontlight ResearchEarly access
Macular degeneration trials in Ireland
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- Where
- Clane, Co. Kildare, Waterford
- Age
- 55 years to 64 years
- People
- 110 worldwide
- Run by
- Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00 - Phase 3Taking peopleVitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
- Where
- Waterford
- Age
- 50 years to 120 years
- People
- 210 worldwide
- Run by
- King's College Hospital NHS Trust
See details and how to joinNCT04663750 · EU 2023-504751-28-00